Insider Selling: Select Medical Holdings Co. (SEM) Chairman Sells $751,233.40 in Stock

Select Medical Holdings Co. (NYSE:SEM) Chairman Robert A. Ortenzio sold 37,468 shares of the firm’s stock in a transaction that occurred on Tuesday, November 6th. The shares were sold at an average price of $20.05, for a total value of $751,233.40. Following the completion of the transaction, the chairman now directly owns 7,251,571 shares in the company, valued at $145,393,998.55. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

SEM opened at $19.50 on Friday. The company has a market capitalization of $2.69 billion, a price-to-earnings ratio of 20.10, a price-to-earnings-growth ratio of 1.35 and a beta of 1.39. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 3.72. Select Medical Holdings Co. has a 12-month low of $15.83 and a 12-month high of $21.65.

Select Medical (NYSE:SEM) last released its earnings results on Thursday, November 1st. The health services provider reported $0.23 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.18 by $0.05. The firm had revenue of $1.27 billion for the quarter, compared to analyst estimates of $1.28 billion. Select Medical had a return on equity of 15.95% and a net margin of 4.32%. The company’s revenue was up 17.7% on a year-over-year basis. During the same quarter last year, the firm posted $0.14 EPS. Research analysts expect that Select Medical Holdings Co. will post 1.05 EPS for the current fiscal year.

SEM has been the topic of a number of recent analyst reports. ValuEngine downgraded Select Medical from a “buy” rating to a “hold” rating in a research note on Wednesday, September 12th. Credit Suisse Group initiated coverage on Select Medical in a research note on Tuesday, October 16th. They issued a “neutral” rating and a $18.00 price objective on the stock. Finally, Zacks Investment Research raised Select Medical from a “sell” rating to a “hold” rating in a research note on Thursday, October 4th. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Select Medical currently has a consensus rating of “Hold” and a consensus target price of $20.83.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in SEM. UBS Group AG grew its holdings in Select Medical by 2,189.3% in the 1st quarter. UBS Group AG now owns 7,738 shares of the health services provider’s stock valued at $133,000 after buying an additional 7,400 shares during the last quarter. Xact Kapitalforvaltning AB grew its holdings in Select Medical by 42.8% in the 1st quarter. Xact Kapitalforvaltning AB now owns 18,011 shares of the health services provider’s stock valued at $311,000 after buying an additional 5,400 shares during the last quarter. Principal Financial Group Inc. grew its holdings in Select Medical by 2.3% in the 1st quarter. Principal Financial Group Inc. now owns 876,489 shares of the health services provider’s stock valued at $15,119,000 after buying an additional 19,600 shares during the last quarter. Foundry Partners LLC grew its holdings in Select Medical by 9.7% in the 2nd quarter. Foundry Partners LLC now owns 781,719 shares of the health services provider’s stock valued at $14,188,000 after buying an additional 68,858 shares during the last quarter. Finally, Cornerstone Wealth Management LLC acquired a new stake in Select Medical in the 2nd quarter valued at approximately $400,000. 75.08% of the stock is currently owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: This piece of content was reported by WKRB News and is the property of of WKRB News. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.wkrb13.com/2018/11/11/insider-selling-select-medical-holdings-co-sem-chairman-sells-751233-40-in-stock.html.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates acute care hospitals (LTCHs), inpatient rehabilitation facilities (IRFs), outpatient rehabilitation clinics, and occupational medicine centers in the United States. The company operates through four segments: Long Term Acute Care, Inpatient Rehabilitation, Outpatient Rehabilitation, and Concentra.

Read More: How is the S&P 500 index different from the DJIA?

Insider Buying and Selling by Quarter for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply